Through direct lobbying, public affairs campaigns, strategic collaborations and community programs, CLS works with government, industry, academia and other stakeholders to shape sound public policy that advances innovation, to promote equity and diversity, to support job creation and skills development and to advocate for all facets of the life sciences within the state of California and beyond.

Latest CLS Policy and Advocacy Updates

Advocacy

FTC Releases Interim Report Highlighting How PBM’s Drive Up Prescription Cost

The Federal Trade Commission (FTC) yesterday released an interim report highlighting how pharmacy benefit managers (PBMs) drive up prescription drug...
Read More
Advocacy

Response to CMS Proposed Guidance for the Next Round of Drug Price Negotiation

CLS submitted comments in response to CMS’ proposed guidance on how they plan to implement the Medicare Drug Price Negotiation...
Read More
Advocacy

Survey Assessing the Environment for Developing Treatments for Rare Diseases

In partnership with the Save Rare Treatments Task Force, CLS is conducting a survey of our membership to gather feedback...
Read More
Advocacy

CLS Statement on Supreme Court Decision to uphold FDA’s Review & Approval Authority

“CLS applauds yesterday’s decision by the Supreme Court to uphold the FDA’s review and approval authority for new medicines. The...
Read More
Advocacy Uncategorized

Advocating for Congress to Establish a Rare Disease Center of Excellence

CLS joined the EveryLife Foundation in sending a letter to Congress, advocating for the inclusion of report language to establish...
Read More
Advocacy Uncategorized

Amplifying Concerns with White House “March-In” Framework

As an advocate for strong life sciences intellectual property rights and a member of the Bayh Dole Coalition, CLS is...
Read More

About Our Federal and State Advocacy Teams

CLS Advocacy BenefitsCalifornia Life Sciences’ team of experienced government relations professionals located in Sacramento, Washington, D.C., and throughout California’s regional municipalities, directly engage with policymakers on issues of critical importance to our members and the continued success of California’s life sciences sector. We engage on federal policy and regulatory items in accordance with the legislative priorities and recommendations of our membership including direct lobbying in Washington, D.C., position and coalition letters, comments and testimony.

The CLS Federal Legislative Committee (FLC) is the primary interface between our membership and identification of the policy items pertinent to CLS’s missions and objectives. The FLC meets monthly to discuss and develop positions and activities regarding federal legislative and regulatory issues of importance to our membership. The FLC also plays an integral role in the development of CLS’s annual federal policy, education, and advocacy agenda.

Our experienced state government relations team engages on behalf of the life sciences sector in multiple ways through strategic collaborations and direct lobbying in Sacramento to advance innovation, investment and job creation for California’s life sciences ecosystem.

In conjunction with the State Legislative Committee (SLC), we identify and develop position statements on issues of interest to CLS’ membership. This SLC group is composed of government affairs professionals at CLS member organizations.

In addition, we aim to favorably shape the policy environment for California’s life sciences industry by creating and leveraging a world class seamless advocacy, public affairs, and government relations program. The team advances a pro-innovation policy agenda, while ensuring patients have access to the right treatment at the right time.

Local

California Life Sciences’ experienced local government relations team engages on behalf of the life sciences sector in multiple ways to advance the innovation, investment, and job creation for California’s life sciences ecosystem.

Local governmental bodies have an increasingly significant impact on the health and growth of California’s life sciences sector. To ensure our voice is heard, CLS provides representation and ensures ongoing dialogue between the industry and local elected officials and agencies throughout California.

Policy and Advocacy News

Policy Priority: R&D Tax Credit and NOL Deductions

Aug 27, 2021

The restoration of California’s Research and Development (R&D) tax credit and Net Operating Loss (NOL) deduction has been one of California Life Sciences’ (CLS) top priorities for 2021.

Read More

[RECAP] Conversation with Thought Leaders: Health Equity

Jun 30, 2021

Watch the recap of Conversation with Thought Leaders: Health Equity, which explored the importance of increasing health access to underserved communities and how the life sciences community can help tackle..

Read More

Top three issues of SB 605: Medical Device Right to Repair Act

Jun 9, 2021

For the 2021-2022 Legislative Session, Senator Susan Eggman (D-Stockton) introduced SB 605, the Medical Device Right to Repair Act, which would allow health care facilities to contract out repairs for..

Read More

Contact Us

Brent Fisk
Senior Vice President, Government Relations & External Affairs
[email protected]
Sam Chung
Vice President, State Government Relations
[email protected]